查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1951829

生物防御市场分析及预测（至2035年）：依类型、产品类型、服务、技术、组件、应用、最终用户、功能、设备划分

Biodefense Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Functionality, Equipment
出版日期: | 出版商: Global Insight Services | 英文 324 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计生物防御市场规模将从2024年的175亿美元成长到2034年的351亿美元，年复合成长率约为6.8%。生物防御市场涵盖旨在保护人民免受生物威胁（包括感染疾病和生物恐怖主义）的策略和技术，包括疫苗、诊断技术和用于预防、检测和应对生物事件的检测系统。日益严峻的全球健康威胁和各国政府的倡议正在推动生物防御能力的进步，尤其註重快速反应和增强应对能力。

由于生物武器和感染疾病威胁日益加剧，生物防御市场正经历强劲成长。检测领域取得了特别显着的进展，先进的诊断系统和生物感测器在早期威胁识别中发挥关键作用。快速诊断试剂盒和携带式检测设备因其高效性和易用性而备受关注。疫苗领域也紧随其后，重组疫苗和合成疫苗的创新发展为抵御新出现的病原体提供了更强的保护。治疗领域（包括抗病毒药物和单株抗体）也取得了重大进展，这反映了对有效治疗方法的迫切需求。将人工智慧 (AI) 和机器学习融入生物防御策略，提供预测性见解和简化的应对机制，正变得日益重要。对研发的投资对于促进创新和确保应对潜在生物威胁的准备至关重要。政府机构和私营部门之间的合作对于加强全球生物防御能力至关重要。

市场区隔
类型 疫苗、治疗药物、诊断试剂、检测设备、监测系统、消毒液、防护设备和资讯技术
产品 炭疽菌、天花、肉毒桿菌中毒、辐射/核辐射、化学武器、伊波拉、兹卡
服务 咨询、培训、支援与维护、託管服务
科技 合成生物学、奈米科技、基因体学、生物资讯学
成分 硬体和软体
应用 民事、军事、紧急应变
最终用户 政府、军队、私人公司、公共卫生机构
功能 侦测、保护、预防、回应和恢復
装置 个人防护设备、侦测设备及去污设备

生物防御市场的特点是众多市场参与企业竞相透过策略定价和创新产品推出争取竞争优势。全球意识的增强和对强大防御机制的需求正推动企业开发先进的生物防御解决方案。市场见证了成熟企业与新Start-Ups之间的动态互动，从而推动了市场环境的不断演变。定价策略竞争激烈，反映了市场对兼具成本效益和先进技术的解决方案的需求。为了满足政府和私营部门不断变化的需求，新产品发布频繁。生物防御市场的竞争异常激烈，领导企业利用先进技术取得竞争优势。区域法规结构对市场动态有显着影响，严格的指导方针塑造产品开发和部署策略。公共和私营部门之间日益密切的合作正在推动创新和部署能力的提升。北美凭藉政府的大量投资保持主导地位，而亚太地区由于生物防御措施的增加，正崛起为一个充满潜力的市场。监管影响和竞争基准之间的相互作用持续决定市场走向，既带来了挑战，也带来了成长机会。

主要趋势和驱动因素：

受生物威胁和流行病日益增长的担忧推动，生物防御市场正经历强劲增长。主要趋势包括各国政府加大对生物防御基础设施和研发的投资。各国优先开发快速诊断工具和疫苗，以因应生物恐怖主义和感染疾病疫情。旨在加强防范和应变能力的公私合营进一步推动了这一趋势。市场驱动因素包括病原体检测和鑑定技术的进步。人工智慧 (AI) 和机器学习在生物防御系统中的应用提高了威胁侦测的准确性和速度。此外，生物安全措施在医疗保健和农业领域的重要性日益凸显，也推动了市场扩张。对先进生物防御解决方案的需求，也因需要强大的监测系统来监测和减轻全球生物威胁而进一步成长。便携式且经济高效的诊断工具的开发存在大量机会，尤其是在新兴国家。投资于创新生物技术解决方案的公司有望占据可观的市场份额。专注于开发下一代疫苗和疗法将带来盈利的成长前景。随着全球对生物风险的认识不断提高，在技术创新和战略合作的推动下，生物防御市场预计将继续扩张。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 疫苗
    • 治疗药物
    • 诊断
    • 检测装置
    • 监控系统
    • 消毒液
    • 防护装备
    • 资讯科技
  • 市场规模及预测：依产品划分
    • 炭疽菌
    • 天花
    • 肉毒桿菌中毒
    • 辐射/核能
    • 化学品
    • 伊波拉
    • 兹卡病毒
  • 市场规模及预测：依服务划分
    • 咨询
    • 训练
    • 支援与维护
    • 託管服务
  • 市场规模及预测：依技术划分
    • 合成生物学
    • 奈米科技
    • 基因组学
    • 生物资讯学
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
  • 市场规模及预测：依应用领域划分
    • 私人的
    • 军队
    • 紧急应变
  • 市场规模及预测：依最终用户划分
    • 政府
    • 军队
    • 私部门
    • 公共卫生机构
  • 市场规模及预测：依功能划分
    • 侦测
    • 保护
    • 预防
    • 一致
    • 恢復
  • 市场规模及预测：依设备划分
    • 个人防护设备
    • 检测设备
    • 消毒设备

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Emergent Bio Solutions
  • Bavarian Nordic
  • Dyn Port Vaccine Company
  • SIGA Technologies
  • Elusys Therapeutics
  • Soligenix
  • Pharm Athene
  • Cangene Corporation
  • Alnylam Pharmaceuticals
  • Bio Factura
  • Achaogen
  • Inovio Pharmaceuticals
  • Chimerix
  • Nanotherapeutics
  • i Bio
  • SAB Biotherapeutics
  • Altimmune
  • Ology Bioservices
  • Spero Therapeutics
  • Vaxart

第九章：关于我们

简介目录
Product Code: GIS10528

Biodefense Market is anticipated to expand from $17.5 billion in 2024 to $35.1 billion by 2034, growing at a CAGR of approximately 6.8%. The Biodefense Market encompasses strategies and technologies aimed at protecting populations against biological threats, including infectious diseases and bioterrorism. It involves vaccines, diagnostics, and detection systems to prevent, detect, and respond to biological incidents. Increasing global health threats and government initiatives are propelling advancements in biodefense capabilities, emphasizing rapid response and resilience.

The Biodefense Market is experiencing robust growth, propelled by the rising threat of biological warfare and infectious diseases. The detection segment leads in performance, with advanced diagnostic systems and biosensors being pivotal in early threat identification. Within this segment, rapid diagnostic kits and portable detection devices are gaining prominence due to their efficiency and ease of use. The vaccines segment follows closely, driven by innovations in recombinant and synthetic vaccines, which offer enhanced protection against emerging pathogens. Therapeutics, including antiviral drugs and monoclonal antibodies, are also witnessing significant advancements, reflecting the urgency for effective treatment options. The integration of artificial intelligence and machine learning in biodefense strategies is becoming increasingly relevant, offering predictive insights and streamlined response mechanisms. Investments in research and development are crucial, fostering innovation and ensuring preparedness against potential biological threats. Collaborative efforts between government entities and private sectors are essential in fortifying global biodefense capabilities.

Market Segmentation
TypeVaccines, Therapeutics, Diagnostics, Detection Devices, Surveillance Systems, Decontamination Solutions, Protective Equipment, Information Technology
ProductAnthrax, Smallpox, Botulism, Radiation/Nuclear, Chemical, Ebola, Zika
ServicesConsulting, Training, Support and Maintenance, Managed Services
TechnologySynthetic Biology, Nanotechnology, Genomics, Bioinformatics
ComponentHardware, Software
ApplicationCivilian, Military, Emergency Response
End UserGovernment, Military, Private Sector, Public Health Organizations
FunctionalityDetection, Protection, Prevention, Response, Recovery
EquipmentPersonal Protective Equipment, Detection Equipment, Decontamination Equipment

The Biodefense Market is characterized by a diverse array of market participants, each vying for competitive advantage through strategic pricing and innovative product launches. Companies are increasingly focusing on developing advanced biodefense solutions, driven by heightened global awareness and the need for robust defense mechanisms. The market witnesses a dynamic interplay of established enterprises and emerging startups, all contributing to the evolving landscape. Pricing strategies remain competitive, reflecting the demand for cost-effective yet technologically advanced solutions. New product launches are frequently observed, as companies strive to meet the evolving needs of governments and private sectors alike. Competition in the Biodefense Market is intense, with key players leveraging advanced technologies to gain a competitive edge. Regulatory frameworks across regions significantly influence market dynamics, with stringent guidelines shaping product development and deployment strategies. The market is witnessing increased collaboration between public and private sectors, enhancing innovation and deployment capabilities. North America remains a dominant force, driven by substantial government investments, while Asia-Pacific is emerging as a lucrative market due to increasing biodefense initiatives. The interplay of regulatory influences and competitive benchmarking continues to define market trajectories, offering both challenges and opportunities for growth.

Geographical Overview:

The biodefense market is witnessing robust growth across various regions, each with unique opportunities. North America leads, driven by significant government investments in biodefense infrastructure and advanced research capabilities. The region's focus on national security and public health preparedness further accelerates market expansion. Europe is also experiencing growth, with increased funding for biodefense initiatives and a strong emphasis on collaborative research efforts. The region's stringent regulatory frameworks and focus on innovation enhance its market potential. In the Asia Pacific, rapid economic development and rising awareness of biological threats are propelling market growth. Key countries like China and India are investing heavily in biodefense technologies and infrastructure. Latin America and the Middle East & Africa are emerging as new growth pockets. In Latin America, increased government attention towards biosecurity measures is evident, while the Middle East & Africa are recognizing the strategic importance of biodefense in ensuring regional stability and security.

The biodefense market is increasingly influenced by global tariffs, geopolitical tensions, and evolving supply chain dynamics. Japan and South Korea are enhancing their biodefense capabilities through innovation and partnerships, mitigating tariff impacts by diversifying suppliers. China is accelerating its domestic biodefense technologies, driven by export restrictions and geopolitical pressures. Taiwan, while central to global semiconductor supply chains, faces vulnerabilities due to regional tensions. The parent market, encompassing public health and security sectors, is witnessing robust growth, propelled by heightened global health threats. By 2035, the market is expected to be characterized by strategic collaborations and technological advancements. Middle East conflicts exacerbate supply chain disruptions and energy price volatility, influencing operational costs and strategic planning in the biodefense sector.

Key Trends and Drivers:

The Biodefense Market is experiencing robust growth, propelled by rising concerns over biological threats and pandemics. Key trends include increased government investments in biodefense infrastructure and research. Nations are prioritizing the development of rapid diagnostic tools and vaccines to counter bioterrorism and infectious disease outbreaks. This trend is further supported by collaborations between public and private sectors to enhance preparedness and response capabilities. Drivers of the market include technological advancements in pathogen detection and identification. The integration of artificial intelligence and machine learning in biodefense systems is improving threat detection accuracy and speed. Additionally, the growing emphasis on biosecurity measures in healthcare and agriculture is fostering market expansion. The demand for advanced biodefense solutions is further fueled by the need for robust surveillance systems to monitor and mitigate biological threats globally. Opportunities abound in the development of portable and cost-effective diagnostic tools, particularly in emerging economies. Companies investing in innovative biotechnology solutions are well-positioned to capture significant market share. The focus on developing next-generation vaccines and therapeutics offers lucrative prospects for growth. As global awareness of biological risks intensifies, the Biodefense Market is poised for continued expansion, driven by technological innovation and strategic partnerships.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Equipment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Vaccines
    • 4.1.2 Therapeutics
    • 4.1.3 Diagnostics
    • 4.1.4 Detection Devices
    • 4.1.5 Surveillance Systems
    • 4.1.6 Decontamination Solutions
    • 4.1.7 Protective Equipment
    • 4.1.8 Information Technology
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Anthrax
    • 4.2.2 Smallpox
    • 4.2.3 Botulism
    • 4.2.4 Radiation/Nuclear
    • 4.2.5 Chemical
    • 4.2.6 Ebola
    • 4.2.7 Zika
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting
    • 4.3.2 Training
    • 4.3.3 Support and Maintenance
    • 4.3.4 Managed Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Synthetic Biology
    • 4.4.2 Nanotechnology
    • 4.4.3 Genomics
    • 4.4.4 Bioinformatics
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Civilian
    • 4.6.2 Military
    • 4.6.3 Emergency Response
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Government
    • 4.7.2 Military
    • 4.7.3 Private Sector
    • 4.7.4 Public Health Organizations
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Detection
    • 4.8.2 Protection
    • 4.8.3 Prevention
    • 4.8.4 Response
    • 4.8.5 Recovery
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Personal Protective Equipment
    • 4.9.2 Detection Equipment
    • 4.9.3 Decontamination Equipment

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Functionality
      • 5.2.1.9 Equipment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Functionality
      • 5.2.2.9 Equipment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Functionality
      • 5.2.3.9 Equipment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Functionality
      • 5.3.1.9 Equipment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Functionality
      • 5.3.2.9 Equipment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Functionality
      • 5.3.3.9 Equipment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Functionality
      • 5.4.1.9 Equipment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Functionality
      • 5.4.2.9 Equipment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Functionality
      • 5.4.3.9 Equipment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Functionality
      • 5.4.4.9 Equipment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Functionality
      • 5.4.5.9 Equipment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Functionality
      • 5.4.6.9 Equipment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Functionality
      • 5.4.7.9 Equipment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Functionality
      • 5.5.1.9 Equipment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Functionality
      • 5.5.2.9 Equipment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Functionality
      • 5.5.3.9 Equipment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Functionality
      • 5.5.4.9 Equipment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Functionality
      • 5.5.5.9 Equipment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Functionality
      • 5.5.6.9 Equipment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Functionality
      • 5.6.1.9 Equipment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Functionality
      • 5.6.2.9 Equipment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Functionality
      • 5.6.3.9 Equipment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Functionality
      • 5.6.4.9 Equipment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Functionality
      • 5.6.5.9 Equipment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Emergent Bio Solutions
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bavarian Nordic
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Dyn Port Vaccine Company
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 SIGA Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Elusys Therapeutics
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Soligenix
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Pharm Athene
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Cangene Corporation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Alnylam Pharmaceuticals
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Bio Factura
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Achaogen
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Inovio Pharmaceuticals
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Chimerix
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Nanotherapeutics
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 i Bio
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 SAB Biotherapeutics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Altimmune
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Ology Bioservices
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Spero Therapeutics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Vaxart
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us